ArticleACS applied materials & interfaces2026
Suppression of Interfacial Loss Pathways at Self-Assembled Molecular Hole Transport Layers in Perovskite Solar Cells.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of stable and efficient perovskite solar cells (PSCs) hinges on the optimization of interfacial energetics and suppression of parasitic loss pathways. While poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine] (PTAA) and [2-(3,6-dimethoxy-9H-carbazol-9-yl)ethyl] phosphonic acid (MeO-2PACz) are among the most effective hole transport layers (HTLs) for inverted PSC architectures, each presents trade-offs between operational and reverse-bias stability. This study introduces a strategy to form a composite HTL comprising PTAA and MeO-2PACz that synergistically integrates both materials' advantages while overcoming their limitations. The composite HTL modulates the buried interface to the perovskite, effectively suppressing loss pathways and enhancing the uniformity of the HTL conductivity. Devices incorporating the composite HTL achieve a champion power conversion efficiency (PCE) of 22.83% without additional surface passivation, surpassing the ∼21% achieved by reference devices made using MeO-2PACz or PTAA alone. Moreover, they demonstrate exceptional operational durability and a markedly enhanced reverse bias tolerance. Accompanying drift-diffusion device simulations suggest a previously unexplored loss mechanism at molecular hole transport layers, related to losses induced by electron tunnelling from the perovskite to the hole-collecting contact. Such loss pathways are suppressed when the composite HTL is used, establishing it as a powerful and scalable route toward highly efficient, durable PSCs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.